Antonio Rueda

Summary

Affiliation: Hospital Costa del Sol
Country: Spain

Publications

  1. pmc Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma
    M Casanova
    Oncohematology Service, Hospital Costa del Sol, Marbella, Spain
    Ther Clin Risk Manag 7:401-8. 2011
  2. pmc Primary leptomeningeal histiocytic sarcoma in a patient with a good outcome: a case report and review of the literature
    Elisabeth Pérez-Ruiz
    Division of Medical Oncology, REDISSEC, Hospital Costa del Sol, Autovía A 7, km 187, Marbella, C, P, 29603, Spain
    J Med Case Rep 7:127. 2013
  3. pmc Has the time to come leave the "watch-and-wait" strategy in newly diagnosed asymptomatic follicular lymphoma patients?
    Antonio Rueda
    Department of Oncology, Hospital Costa del Sol, Marbella, Spain
    BMC Cancer 12:210. 2012
  4. ncbi request reprint Pralatrexate, a new hope for aggressive T-cell lymphomas?
    Antonio Rueda
    Servicio de Oncohematología, Hospital Costa del Sol, Autovía A 7, km 187, Marbella, Malaga, Spain
    Clin Transl Oncol 11:215-20. 2009
  5. doi request reprint Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 tumor expression in patients with advanced laryngeal cancer after induction chemotherapy for organ preservation
    Antonio Rueda
    Department of Oncology, Hospital Costa del Sol, Marbella, Spain
    Head Neck 33:808-16. 2011
  6. pmc Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer
    Bella Pajares
    Department of Medical Oncology, University Hospital Virgen de la Victoria, Malaga, Spain
    BMC Cancer 13:26. 2013
  7. ncbi request reprint Presentation of Hodgkin's lymphoma with Ophelia syndrome
    David Olmos
    Oncology Department, Hospital Clinico Universitario, Malaga, Spain
    J Clin Oncol 25:1802-3. 2007
  8. pmc Detection methods predict differences in biology and survival in breast cancer patients
    Maximino Redondo
    Research Unit, Hospital Costa del Sol, University of Malaga, Red de Investigación en Servicios de Salud en Enfermedades Crónicas REDISSEC, Carretera de Cádiz Km 187, 29600 MarbellaMálaga, Spain
    BMC Cancer 12:604. 2012
  9. ncbi request reprint Treatment for relapse in stage I/II Hodgkin's lymphoma after initial single-modality treatment
    Antonio Rueda
    Oncology Department, Hospital Clinico Universitario, Malaga, Spain
    Clin Lymphoma Myeloma 6:389-92. 2006
  10. doi request reprint Clusterin expression is associated with decreased disease-free survival of patients with colorectal carcinomas
    Maximino Redondo
    Department of Biochemistry, Hospital Costa del Sol, CIBER Epidemiología y Salud Pública, Universidad de Malaga, Malaga, Spain
    Histopathology 56:932-6. 2010

Collaborators

Detail Information

Publications17

  1. pmc Critical appraisal of pralatrexate in the management of difficult-to-treat peripheral T cell lymphoma
    M Casanova
    Oncohematology Service, Hospital Costa del Sol, Marbella, Spain
    Ther Clin Risk Manag 7:401-8. 2011
    ..Future areas of development are now focused on identifying synergistic combinations of pralatrexate with other agents and the evaluation of predictive markers for clinical benefit...
  2. pmc Primary leptomeningeal histiocytic sarcoma in a patient with a good outcome: a case report and review of the literature
    Elisabeth Pérez-Ruiz
    Division of Medical Oncology, REDISSEC, Hospital Costa del Sol, Autovía A 7, km 187, Marbella, C, P, 29603, Spain
    J Med Case Rep 7:127. 2013
    ..We present the first case of a patient with histiocytic sarcoma that involved the meninges and had a good course after multidisciplinary treatment...
  3. pmc Has the time to come leave the "watch-and-wait" strategy in newly diagnosed asymptomatic follicular lymphoma patients?
    Antonio Rueda
    Department of Oncology, Hospital Costa del Sol, Marbella, Spain
    BMC Cancer 12:210. 2012
    ..Based on these facts, most clinical practice guidelines recommend active surveillance policies for patients with asymptomatic FL...
  4. ncbi request reprint Pralatrexate, a new hope for aggressive T-cell lymphomas?
    Antonio Rueda
    Servicio de Oncohematología, Hospital Costa del Sol, Autovía A 7, km 187, Marbella, Malaga, Spain
    Clin Transl Oncol 11:215-20. 2009
    ....
  5. doi request reprint Vascular endothelial growth factor and vascular endothelial growth factor receptor-2 tumor expression in patients with advanced laryngeal cancer after induction chemotherapy for organ preservation
    Antonio Rueda
    Department of Oncology, Hospital Costa del Sol, Marbella, Spain
    Head Neck 33:808-16. 2011
    ....
  6. pmc Differential outcome of concurrent radiotherapy plus epidermal growth factor receptor inhibitors versus radiotherapy plus cisplatin in patients with human papillomavirus-related head and neck cancer
    Bella Pajares
    Department of Medical Oncology, University Hospital Virgen de la Victoria, Malaga, Spain
    BMC Cancer 13:26. 2013
    ....
  7. ncbi request reprint Presentation of Hodgkin's lymphoma with Ophelia syndrome
    David Olmos
    Oncology Department, Hospital Clinico Universitario, Malaga, Spain
    J Clin Oncol 25:1802-3. 2007
  8. pmc Detection methods predict differences in biology and survival in breast cancer patients
    Maximino Redondo
    Research Unit, Hospital Costa del Sol, University of Malaga, Red de Investigación en Servicios de Salud en Enfermedades Crónicas REDISSEC, Carretera de Cádiz Km 187, 29600 MarbellaMálaga, Spain
    BMC Cancer 12:604. 2012
    ..The aim of this study was to measure the biological characteristics involved in tumorigenesis and the progression of breast cancer in symptomatic and screen-detected carcinomas to identify possible differences...
  9. ncbi request reprint Treatment for relapse in stage I/II Hodgkin's lymphoma after initial single-modality treatment
    Antonio Rueda
    Oncology Department, Hospital Clinico Universitario, Malaga, Spain
    Clin Lymphoma Myeloma 6:389-92. 2006
    ..This article focuses on the outcome of 11 limited-stage patients who relapsed after ABVD alone...
  10. doi request reprint Clusterin expression is associated with decreased disease-free survival of patients with colorectal carcinomas
    Maximino Redondo
    Department of Biochemistry, Hospital Costa del Sol, CIBER Epidemiología y Salud Pública, Universidad de Malaga, Malaga, Spain
    Histopathology 56:932-6. 2010
    ..The aim of this study was to determine the clinicopathological significance of clusterin expression in human colorectal carcinomas...
  11. doi request reprint Efficacy and safety of weekly paclitaxel combined with cetuximab in the treatment of pretreated recurrent/metastatic head and neck cancer patients
    Begoña Jiménez
    Hospital Universitario Virgen de la Victoria, Department of Medical Oncology, Malaga, Spain
    Oral Oncol 49:182-5. 2013
    ..However, this combination has been widely extended to patients who present resistance to first line chemotherapy (CT) or those who are not candidates for platinum-based CT...
  12. ncbi request reprint Mantle cell lymphoma stage IV affecting lacrimal glands, retro-orbital tissue, optic nerve and ocular motor muscles
    Bella Pajares-Hachero
    Medical Oncology Department, Hospital Clinico Virgen de la Victoria, Campus Universitario Teatinos, Malaga, Spain
    Clin Transl Oncol 11:484-5. 2009
    ..The patient was treated with rituximab and chemotherapy, achieving a complete response of those lesions...
  13. ncbi request reprint Elevated vascular endothelial growth factor pretreatment levels are correlated with the tumor burden in Hodgkin lymphoma and continue to be elevated in prolonged complete remission
    Antonio Rueda
    Oncology Department, Hospital Clinico Universitario, Malaga, Spain
    Clin Lymphoma Myeloma 7:400-5. 2007
    ..Hodgkin lymphoma represents approximately one fifth of all lymphomas, and the roles of angiogenesis and VEGF in Hodgkin lymphoma have not been well defined at present...
  14. ncbi request reprint R-CHOP-14 in patients with diffuse large B-cell lymphoma younger than 70 years: a multicentre, prospective study
    Antonio Rueda
    Medical Oncology Service, Hospital Clinico Universitario, Malaga, Spain
    Hematol Oncol 26:27-32. 2008
    ..With a median follow-up of 26 months, progression-free survival (PFS) and overall survival (OS) at 30 months were 72% and 86%, respectively. Administration of R-CHOP-14 is feasible and effective in patients <70 years...
  15. ncbi request reprint A phase II study of concomitant boost radiation plus concurrent weekly cisplatin for locally advanced unresectable head and neck carcinomas
    José Antonio Medina
    Servicio de Oncologia Radioterapica, Hospital Clinico Universitario, Malaga, Spain
    Radiother Oncol 79:34-8. 2006
    ..This phase II study evaluated the efficacy and toxicity of weekly cisplatin along with concomitant boost accelerated radiation regimen in patients with locally advanced unresectable head and neck carcinoma...
  16. doi request reprint Aggressiveness features and outcomes of true interval cancers: comparison between screen-detected and symptom-detected cancers
    Laia Domingo
    Epidemiology and Evaluation Department, Hospital del Mar IMIM, Barcelona, Spain
    Eur J Cancer Prev 22:21-8. 2013
    ..Clinically detected tumors, especially true interval cancers, more frequently showed biological features related to worse prognosis and were associated with poorer survival even after adjustment for clinical-pathological characteristics...
  17. doi request reprint Regulation of clusterin expression in human cancer via DNA methylation
    Alfonso Serrano
    Department of Immunology, Hospital Clinico Universitario, Campus Universitario Teatinos, Malaga, Spain
    Tumour Biol 30:286-91. 2009
    ..The present study was designed to examine the role of clusterin methylation as an indicator of clusterin expression in tumor cell lines and breast tissue samples...